GlassScriptPhysician profile
Clark The Bach
NPI 1831579689
$3,163.56
in general payments reported to CMS, 2019-2025
22 companies · $442 in 2025
The $442 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.43 · 2022: $1,900 · 2023: $378 · 2024: $401 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,221.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $1,900.10 | 2022 | |
| Glaxosmithkline, LLC. | $198.81 | 2024-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbott Laboratories | $144.98 | 2023-2025 | Assurity, Freestyle Libre 3 |
| Lilly USA, LLC | $143.60 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $120.81 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Genzyme Corporation | $84.78 | 2024 | |
| Exact Sciences Corporation | $70.62 | 2023 | Cologuard Collection Kit |
| Astellas Pharma US INC | $58.73 | 2024 | Veozah |
| Pfizer INC. | $55.69 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $55.19 | 2023-2024 | Farxiga |
| Phadia US INC. | $49.17 | 2023-2025 | Immunocap |
| Bayer Healthcare Pharmaceuticals INC. | $45.57 | 2025 | |
| Scilex Pharmaceuticals INC. | $42.43 | 2019 | |
| Sanofi-Aventis U.S. LLC | $35.88 | 2024 | |
| Boston Scientific Corporation | $35.42 | 2025 | General - Pain Management |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $24.11 | 2023 | Dexcom G6 Transmitter |
| Alnylam Pharmaceuticals INC. | $21.61 | 2025 | Amvuttra |
| Baxter Healthcare | $17.28 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.08 | 2023 | Ofev |
| Amgen INC. | $16.38 | 2025 | Evenity |
| Philips North America LLC | $13.96 | 2024 | (Ck7) Extended Holter |
| Cequr Corporation | $11.36 | 2023 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clark Bach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.